Waters Corporation and PREMIER Biosoft International Announce Collaboration for Advancing Lipidomics Research
News Jun 07, 2011
Waters Corporation has announced it has entered into a non-exclusive co-marketing and reselling agreement with PREMIER Biosoft International (Palo Alto, CA) to advance lipidomics research.
Waters will offer PREMIER Biosoft’s SimLipid® informatics platform for sale with Waters® ACQUITY UPLC® and high-resolution, exact mass SYNAPT® and XEVO® mass spectrometers for lipid analysis. PREMIER Biosoft released its SimLipid software product earlier in 2011.
Responding to the challenges set forth by leading lipid researchers, Waters exact mass UPLC/MS systems for lipid analysis combine UltraPerformance LC® and proprietary ion mobility mass spectrometry technology with advanced lipidomics informatics for comprehensive and rigorous lipid characterization from complex biological samples.
Ion mobility, found only with Waters SYNAPT mass spectrometers, brings an additional, orthogonal dimension of sample separation to lipid analysis. This technology provides greater levels of specificity and class separation to lipid analysis, including the separation of isobaric/isomeric lipid species.
“Waters UPLC, ion mobility, advanced mass spectrometry and informatics technologies have created a lipid analysis platform which provides greater insight into our complex biological investigations than ever before," says Professor Jeremy K. Nicholson, Head of Surgery and Cancer, Imperial College London, a Waters Center of Innovation.
Waters Centers of Innovation Program recognizes and supports the research of leading scientists and institutions around the world in numerous application areas including metabolomics and lipidomics.
PREMIER Biosoft’s SimLipid augments the Waters UPLC - HDMSe (ion mobility - mass spectrometry) data by performing an exact mass precursor ion search to generate a list of lipid candidates which are then ranked by comparing diagnostic product ions observed in the high energy HDMSe data and structure specific in-silico fragment ions from the SimLipid database.
Interpretation of spectra has been made easy by annotating matched peaks with corresponding compounds. SimLipid generates portable reports and images in different file formats such as XLS, CSV, HTML, JPEG and PNG to facilitate dynamic information sharing. In addition, each structure is mined for its associated class, reaction, pathway and enzyme, so that scientists don’t waste time and money on laborious manual annotation.
According to Kay Brown, President at PREMIER Biosoft, “PREMIER Biosoft is very pleased to work with Waters Corporation to offer a whole product solution to the lipidomics and glycobiology research community.”
In a 2010 press release, Waters and PREMIER Biosoft announced an agreement to co-market PREMIER Biosoft’s SimGlycan data analysis software tool. SimGlycan is a high throughput data analysis tool for glycan and glycopeptide structure elucidation.
Under the terms of the new agreement, Waters will continue to sell and support its UPLC and mass spectrometers for lipid analysis, while PREMIER Biosoft will market its characterization tool to Waters customers analyzing lipid data.
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule InhibitorsNews
A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.READ MORE